These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10946222)

  • 1. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide.
    Carr A; Frei B
    Free Radic Biol Med; 2000 Jun; 28(12):1806-14. PubMed ID: 10946222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does ascorbic acid prevent endothelial dysfunction?
    May JM
    Free Radic Biol Med; 2000 May; 28(9):1421-9. PubMed ID: 10924860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction.
    Frei B
    Proc Soc Exp Biol Med; 1999 Dec; 222(3):196-204. PubMed ID: 10601878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.
    Vanhoutte PM; Zhao Y; Xu A; Leung SW
    Circ Res; 2016 Jul; 119(2):375-96. PubMed ID: 27390338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in human disease.
    Drexler H; Hornig B
    J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-derived nitric oxide: actions and properties.
    Ignarro LJ
    FASEB J; 1989 Jan; 3(1):31-6. PubMed ID: 2642868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial function and oxidative stress in cardiovascular diseases.
    Higashi Y; Noma K; Yoshizumi M; Kihara Y
    Circ J; 2009 Mar; 73(3):411-8. PubMed ID: 19194043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease.
    Lyons D
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S101-9. PubMed ID: 9488201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function.
    Kinlay S; Behrendt D; Fang JC; Delagrange D; Morrow J; Witztum JL; Rifai N; Selwyn AP; Creager MA; Ganz P
    J Am Coll Cardiol; 2004 Feb; 43(4):629-34. PubMed ID: 14975474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial control of vasomotion and nitric oxide production: a potential target for risk factor management.
    Harrison DG
    Cardiol Clin; 1996 Feb; 14(1):1-15. PubMed ID: 9072283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia.
    Gilligan DM; Sack MN; Guetta V; Casino PR; Quyyumi AA; Rader DJ; Panza JA; Cannon RO
    J Am Coll Cardiol; 1994 Dec; 24(7):1611-7. PubMed ID: 7963105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide: orchestrator of endothelium-dependent responses.
    Félétou M; Köhler R; Vanhoutte PM
    Ann Med; 2012 Nov; 44(7):694-716. PubMed ID: 21895549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system.
    Lüscher TF
    Eur Heart J; 1991 Nov; 12 Suppl E():2-11. PubMed ID: 1790780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations.
    McHugh J; Cheek DJ
    Am J Crit Care; 1998 Mar; 7(2):131-40; quiz 141-2. PubMed ID: 9509227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and alkalinization inhibit endothelium-derived nitric oxide but not endothelium-derived hyperpolarizing factor responses in porcine coronary artery.
    Shimizu S; Paul RJ
    J Pharmacol Exp Ther; 1999 Oct; 291(1):335-44. PubMed ID: 10490922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.
    Tanner FC; Noll G; Boulanger CM; Lüscher TF
    Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids and the endothelium.
    Dart AM; Chin-Dusting JP
    Cardiovasc Res; 1999 Aug; 43(2):308-22. PubMed ID: 10536661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.